Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
FluoSphera Expands Its Systemic Technology Platform to empower ADCs to meet their promise
-
Alight Study Reveals Workers Are Seeking Increased Support From Employers Amid Wellbeing Crisis
-
Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer
-
U.S. Bank Freight Payment Index: Truck freight volume, spend decline at slower pace
-
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
-
Gartner to Participate in the J.P. Morgan Ultimate Services Investor Conference
-
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
-
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
-
Inovalon’s Converged Quality Solution Customers Realized a 5% Increase in Star Ratings Score, Including Nearly 60% of All Medicare Health Plans Which Received CMS’ Highest 5-Star Rating
-
Ovid Therapeutics to Host Investor Event
-
Barinthus Bio Announces Late Breaking Presentation at AASLD 2024 – The Liver Meeting® and Attendance at November Conferences
-
Athene Announces CFO Martin P. Klein to Retire from Role
-
426% ROI delivered by Cynet in Forrester Total Economic Impact™ Study
-
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
-
PodcastOne Engages MZ Group to Lead Strategic Investor Relations Program
-
aTyr Pharma to Present at Upcoming Investor Conferences
-
Autonomix Medical, Inc. Reports New Positive Topline Results from First 15 Patients’ 7-Day Data Highlighting Significant Impact on Treatment of Pancreatic Cancer Pain with Maintained Pain Reduction
-
Konica Minolta Healthcare and Quinsite Partner to Bring Comprehensive Workflow and Operational Analytics to Exa Platform Users
-
BD² and DBSA Partner to Improve the Lives of People Living With Bipolar Disorder
-
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
-
UYBA Volley Battles Back with Consecutive Wins in Serie A1
-
Nearly 80% of Consumers Consider Phone Channel Important for Communicating with Businesses, Despite Reluctance to Answer Calls
-
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024
-
Outbrain Deepens Collaboration with Microsoft – Integrates AI Solutions into Its Offerings
-
Cognyte Customer in EMEA Safeguards National Interests with $20-plus Million Agreement
-
The Geological Society of America Acquires Mountain Press Publishing Company’s Renowned Geology Book Series
-
Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins
-
Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024
-
Crown to Report Third Quarter 2024 Results on November 14, 2024
-
IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
-
Deepfake Fraud Costs the Financial Sector an Average of $600,000 for Each Company, Regula’s Survey Shows
-
Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
-
Monster Beverage to Report Financial Results for 2024 Third Quarter on November 7, 2024
-
Resilinc Announces Chris Lanier as New Chief Technology Officer
-
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for SBT101, its Gene Therapy Candidate in Adrenomyeloneuropathy (AMN)
-
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
-
Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference
-
Spiritus Announces Manufacturing Facility in Missouri to Produce Novel Sorbent for Direct Air Capture Carbon Removal
-
Vertex Advances Tax Technology Innovation at Exchange 2024
-
Esperion Announces a Featured Presentation in the Late Breaker/Featured Science Track and Three Poster Presentations Accepted for the 2024 American Heart Association (AHA) Scientific Sessions
-
VEON to release 3Q 2024 trading update on 14 November 2024
-
Evaxion announces business update and third quarter 2024 financial results
-
Oxford BioTherapeutics to Present at World ADC Conference 2024
-
BlackBerry QNX Introduces Software-Defined Functional Safety Platform In Collaboration With Intel For Industrial Automation
-
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
-
Accenture Collaborates with 1910 Genetics to Help Biopharma Companies Transform Drug Discovery with AI
-
Saddleback Mountain Ranked No. 2 in the East by SKI Magazine
-
ZenaTech's ZenaDrone Completes the First Phase of an IQ Nano Inventory Management Trial for Multinational Auto Parts Customer
-
Sabre's third quarter 2024 earnings materials available on its Investor Relations website
-
Polaris Renewable Energy Declares Quarterly Dividend
